Does donor race still make a difference in deceased-donor African-American renal allograft recipients?

Am J Surg. 2010 Mar;199(3):305-9; discussion 309. doi: 10.1016/j.amjsurg.2009.08.025.

Abstract

Background: Prior studies have demonstrated that African-American (AA) donor kidneys are independently associated with an increased risk for graft loss.

Methods: We examined outcomes in comparable groups of AA deceased-donor (DD) kidney transplant patients receiving an AA donor (n=35) versus a Caucasian donor (C group; n=150) organ.

Results: There were no differences between AA and C groups in patient survival, new-onset diabetes, or BK nephropathy. The AA group demonstrated a significantly higher 6-month and overall incidence of acute rejection (AR), increased cytomegalovirus (CMV) infection, and decreased graft survival. Recurrent or de novo focal segmental glomerulosclerosis (FSGS) accounted for a significantly higher fraction of graft losses in the AA versus C group.

Conclusions: AA DD renal allograft recipients have equivalent patient but decreased graft survival when transplanted with an AA versus C kidney using current immunosuppression. This may be the result of increased AR, CMV infection, and recurrence/development of FSGS.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Black or African American*
  • Female
  • Graft Rejection / epidemiology
  • Graft Survival
  • Humans
  • Kidney Transplantation*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Tissue Donors*
  • White People*